vTv Therapeutics Announces 2021 fourth Quarter and Full Year

/PRNewswire/ -- vTv Therapeutics Inc. (Nasdaq: VTVT) today reported financial results for the fourth quarter and year ended December 31, 2021, and provided an...

Related Keywords

United States , America , Anteris Bio , Corporate Development For Macandrews Forbes Incorporated , American Diabetes Association Scientific Sessions On , Company Board Of Directors , Reneo Pharmaceuticals Inc , Drug Administration , Vtv Therapeutics , Tv Therapeutics Inc , Corporate Business Development Of Vericast Corp , Nasdaq , Therapeutics Inc , Newsoara Biopharma Co Ltd , Novo Nordisk , Hangzhou Zhongmei Huadong Pharmaceutical Co , Therapy Designation , Richard Nelson , Acting Chief Executive , Executive Vice President Corporate , Business Development , Vericast Corp , Executive Vice President Corporate Development , North America , Diabetes Obesity , American Diabetes Association Scientific Sessions , Reneo Pharmaceuticals , Related Party Warrants , Loss Before Non Controlling Interest , Non Controlling Interest , Loss Per Share , Hangzhou Zhongmei Huadong Pharmaceutical , Reneo License Agreements , Related Party , Redeemable Noncontrolling Interest , Consolidated Statements , Common Stock , Year Ended , Annual Report , Classb Common Stock , Vtv Therapeutics Inc ,